Company Filing History:
2 out of 7 
1 out of 1 
1 out of 5 
Years Active: 2021-2025
Title: Claus Hallwirth: Innovator in AAV Research
Introduction
Claus Hallwirth is a notable inventor based in Parramatta, Australia. He has made significant contributions to the field of adeno-associated virus (AAV) research, holding 2 patents that focus on innovative polypeptides and nucleic acid molecules derived from marsupial AAV.
Latest Patents
His latest patents include "AAV capsid polynucleotides and polypeptides and virions containing the same." This patent relates to polypeptides derived from marsupial AAV, including nucleic acid molecules encoding these polypeptides and vectors that comprise them. The disclosure also covers the uses of these nucleic acid molecules, polypeptides, and AAV vectors for capsid diversification. Another significant patent is "Adeno-associated virus polynucleotides, polypeptides and virions," which discusses polypeptides encoded by an AAV-derived endogenous viral element found within the germline of various closely-related marsupial species.
Career Highlights
Claus has worked with esteemed organizations such as the Children's Medical Research Institute and The Sydney Children's Hospital Network, which incorporates the Royal Alexandra Hospital for Children. His work has been pivotal in advancing the understanding of AAV and its applications in medical research.
Collaborations
He has collaborated with notable professionals in the field, including Ian Alexander and Richard Smith. Their combined expertise has contributed to the success of various research initiatives.
Conclusion
Claus Hallwirth's innovative work in AAV research and his contributions to the scientific community highlight his role as a leading inventor in this specialized field. His patents and collaborations continue to influence advancements in medical research and applications.